The Manufacturing Chemist anticounterfeiting roundtable: part II

Published: 16-Nov-2017
Media Regulatory

In the second part of a two-part roundtable, Manufacturing Chemist speaks to a group of industry leaders about the additional benefits that can be achieved through serialisation beyond compliance and what comprehensive track and trace regulations, including aggregation, could mean for the future of the industry

You need to be a subscriber to read this article.
Click here to find out more.

Serialisation presents a huge challenge for pharmaceutical companies and their contract partners. The complexities associated with developing and implementing a solution across multiple lines, supplying to multiple markets and then managing the huge amounts of data generated as a result of serialisation are vast.

However, well prepared companies that are ready for the US and European regulatory deadlines ahead of time are increasingly realising that there are additional business benefits to be gained from serialisation and the end-to-end supply chain visibility it could potentially offer. Many companies are suggesting that serialisation and track and trace regulations could have wider business benefits beyond compliance. Have you found this to be true and, if so, how?

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
  • Companies:
  • Recipharm
  • TraceLink Inc
  • Tjoapack
  • SEA Vision SRL
See more

You may also like

Packaging

Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future

Read more
To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack

Trending Articles

  1. Accelerating and enhancing toxicology assessments Infographic guides users through ToxHQ’s speedy assessment features
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  3. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services
  5. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Packaging

Navigating regulatory challenges in pharmaceutical packaging: lessons from the past and strategies for the future

To safeguard drug efficacy, maintain strict quality standards and ensure patient safety, pharmaceutical packaging is subject to a wide range of regulations around the world, reports Kun Shing Chan, Director of QA at Tjoapack
Packaging

Changes ahead as the US FDA proposes longer national drug codes

The national drug code (NDC) is a unique number used by the US Food and Drug Administration (FDA) to identify and report drugs
Media

Industry spotlight: packaging trends in turbulent times

As if Brexit, the scaled-up production of vaccines and spiralling demand for cold chain storage wasn’t enough, Dr Kevin Robinson spoke to Recipharm’s Lukas Spanier and Sharp Services’ Alexander Schäfer to get an insider’s view on the biggest pharmaceutical packaging trends of 2021
Regulatory

Recipharm names 2020 International Environmental Award winner

Recipharm names 2020 International Environmental Award winner The prize ceremony will take place later during spring 2021 and will be set up in an appropriate format considering the development of the COVID-19 pandemic
Regulatory

Recipharm bolsters biologics offering

The license applies to the company’s Wasserburg, Germany facility
Regulatory

Henry Schein implements TraceLink verification router service

The implementation comes ahead of the November 2020 enforcement deadline for the Drug Supply Chain Security Act (DSCSA) saleable returns verification requirement
Media

Manufacturing Chemist roundtable: Pharmaceutical trends to keep an eye on

From cannabis to containment and from regulatory affairs to Russia, 2019 presented the pharmaceutical industry with a number of hurdles and opportunities. A panel of industry experts examine how the slings and arrows of the past twelve months might affect the next ten years
Subscribe now